Patient characteristics
| No. of patients | 154 |
| Sex ratio, M/F | 97/57 |
| Median age, y (range) | 28 (3-63) |
| Study, no. of patients | 154 |
| LAME-91 | 45 |
| ALFA-9000 | 29 |
| BGMT-87 | 8 |
| BGMT-91 | 16 |
| GOELAM-01 | 29 |
| GOELAM-02 | 27 |
| Extramedullary disease, no. of patients | |
| Granulocytic sarcoma | 8 |
| Central nervous system involvement | 1 |
| Both | 3 |
| WBC, no. of patients | 154 |
| Median WBC (range) | 12 G/L (1.4-168) |
| 75th percentile upper limit | 24 G/L |
| 90th percentile upper limit | 41 G/L |
| 95th percentile upper limit | 67 G/L |
| 99th percentile upper limit | 105 G/L |
| Marrow blast percentage, no. of patients | 150 |
| Median marrow blast percentage, range | 60% (7%-100%) |
| 1st percentile lower limit | 20% |
| 5th percentile lower limit | 28% |
| 10th percentile lower limit | 31% |
| 25th percentile lower limit | 43% |
| Cytogenetics, no. of patients | 154 |
| AN/AA/information not available | 53/95/6 |
| Associated LOS | 67 |
| Associated del(9q) | 13 |
| Associated complex abnormalities | 3 |
| No. of patients | 154 |
| Sex ratio, M/F | 97/57 |
| Median age, y (range) | 28 (3-63) |
| Study, no. of patients | 154 |
| LAME-91 | 45 |
| ALFA-9000 | 29 |
| BGMT-87 | 8 |
| BGMT-91 | 16 |
| GOELAM-01 | 29 |
| GOELAM-02 | 27 |
| Extramedullary disease, no. of patients | |
| Granulocytic sarcoma | 8 |
| Central nervous system involvement | 1 |
| Both | 3 |
| WBC, no. of patients | 154 |
| Median WBC (range) | 12 G/L (1.4-168) |
| 75th percentile upper limit | 24 G/L |
| 90th percentile upper limit | 41 G/L |
| 95th percentile upper limit | 67 G/L |
| 99th percentile upper limit | 105 G/L |
| Marrow blast percentage, no. of patients | 150 |
| Median marrow blast percentage, range | 60% (7%-100%) |
| 1st percentile lower limit | 20% |
| 5th percentile lower limit | 28% |
| 10th percentile lower limit | 31% |
| 25th percentile lower limit | 43% |
| Cytogenetics, no. of patients | 154 |
| AN/AA/information not available | 53/95/6 |
| Associated LOS | 67 |
| Associated del(9q) | 13 |
| Associated complex abnormalities | 3 |
AN indicates simultaneous presence of normal and abnormal metaphases; AA, presence of abnormal metaphases only; G/L = 109/L.